TIP47 Antibody
Code | Size | Price |
---|
PSI-3881-0.02mg | 0.02mg | £150.00 |
Quantity:
PSI-3881-0.1mg | 0.1mg | £449.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunofluorescence (IF)
- Immunohistochemistry (IHC)
- Western Blot (WB)
Images
Documents
Further Information
Additional Names:
TIP47 Antibody: PP17, TIP47, M6PRBP1, Perilipin-3, 47 kDa mannose 6-phosphate receptor-binding protein, 47 kDa MPR-binding protein
Application Note:
WB: 0.5-4 μg/mL; IHC-P: 10 μg/mL; IF: 20 μg/mL.
Antibody validated: Western Blot in human and rat samples; Immunohistochemistry in rat samples; Immunofluorescence in rat samples. All other applications and species not yet tested.
Antibody validated: Western Blot in human and rat samples; Immunohistochemistry in rat samples; Immunofluorescence in rat samples. All other applications and species not yet tested.
Background:
TIP47 Antibody: Tail-interacting protein (TIP47) is a cytosolic protein essential for the transport of mannose-6-phosphate receptors (MPRs) from endosomes to the trans-Golgi compartments in cells. TIP47 is recruited from the cytoplasm to the late endosomal surface by the Ras-associated protein Rab9 GTPase, enabling it to bind more efficiently to MPR cytoplasmic domains. Recently, it was shown that TIP47 regulates the expression of Rab9, as expression of siRNA to TIP47 in transfected cells dramatically decreased the half-life of the Rab9 protein in addition to stabilizing the subcellular localization of Rab9. At least two isoforms of TIP47 are known to exist.
Background References:
- Barbero et al. J. Cell Biol. 2002; 156:511-8.
- Carroll et al. Science 2001; 292:1373-7.
- Aivazian et al. J. Cell Biol. 2006; 173:917-26.
- Ganley et al. Mol. Biol. Cell 2004; 15:5420-30.
Buffer:
TIP47 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted species reactivity based on immunogen sequence: Pig: (86%)
Immunogen:
Anti-TIP47 antibody (3881) was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human TIP47.
The immunogen is located within the last 50 amino acids of TIP47.
The immunogen is located within the last 50 amino acids of TIP47.
ISOFORMS:
Human TIP47 has 4 isoforms, including isoform 1 (434aa, 47kD), isoform 2 (251aa, 28kD), isoform 3 (433aa, 47kD), isoform 4 (422aa, 46kD). Mouse TIP47 has one isoform (437aa, 47kD) and rat TIP47 also has one isoform (438aa, 47kD). 3883 can detect all human isoforms, and can also detect mouse and rat TIP47.
NCBI Gene ID #:
10226
NCBI Official Name:
perilipin 3
NCBI Official Symbol:
PLIN3
NCBI Organism:
Homo sapiens
Physical State:
Liquid
PREDICTED MOLECULAR WEIGHT:
Predicted: 47kD
Observed: 47kD
Observed: 47kD
Protein Accession #:
O60664
Protein GI Number:
68846601
Purification:
TIP47 Antibody is affinity chromatography purified via peptide column.
Research Area:
Signal Transduction,Neuroscience
Swissprot #:
O60664
User NOte:
Optimal dilutions for each application to be determined by the researcher.
VALIDATION:
Independent Antibody Validation in Cell lines (Figure 2) shows similar TIP47 expression profile in human cell lines detected by two independent anti-TIP47 antibodies that recognize different epitopes, 3883 against N-terminus domain and 3881 against C-terminus domain. TIP47 proteins are detected in the most tested cell lines at different expression levels by the two independent antibodies.
Induced Expression Validation (Figure 6-8): TIP47 expression detected by anit-TIP47 antibodies was increased in Atg7 liver KO mice (figure 6), after starvation (figure 7), or after oleic acid treatment (figure 8).
References
Related Products
Product Name | Product Code | Supplier | TIP47 Peptide | PSI-3881P | ProSci | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|